Development of immunotherapies for type 1 diabetes. Value and limitations of mouse models.
40 min
Prof. Matthias von Herrath Eli Lilly and Company, USA
3 TalksBiography
Prof. von Herrath is a Senior Medical Executive with 30+ years of healthcare leadership spanning academic immunology research, Institute leadership, and pharmaceutical R&D. Proven track record of building high-performing units (up to 150 people), managing $50M+ portfolios, and successfully prioritizing novel therapeutic approaches in biotech and academia. Expert in translational... read moremedicine, clinical drug development, and regulatory strategy with a focus on cross-functional collaboration.
